Evidence map›Paper›PMID 21792677›Full record

ArticleNeurochemical research2011

Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons.

Se Jin Jeon, So Young Rhee, Jong Hoon Ryu, Jae Hoon Cheong, Kyungja Kwon, Sung-Il Yang, Seung Hwa Park, Jongmin Lee, Hahn Young Kim, Seol-Heui Han and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 61 citations in OpenAlex.

  1. Nociceptive adenosine AInternational journal of oral science · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Neonatal Seizures and Purinergic Signalling.International journal of molecular sciences · 2020
    Review
  12. Tumor Immunotherapy Using APharmaceuticals (Basel, Switzerland) · 2020
    Review
  13. Effects of an adenosine AJournal of psychopharmacology (Oxford, England) · 2020
    Article
  14. Article
  15. Glycogen synthase kinase 3 beta regulates ethanol consumption and is a risk factor for alcohol dependence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  16. Article
  17. Purinergic system in psychiatric diseases.Molecular psychiatry · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Se Jin JeonDepartment of Pharmacology, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
So Young Rhee
Jong Hoon Ryu
Jae Hoon Cheong
Kyungja Kwon
Sung-Il Yang
Seung Hwa Park
Jongmin Lee
Hahn Young Kim
Seol-Heui Han
Kwang Ho Ko
Chan Young Shin
Konkuk University · KRSeoul National University · KRKyung Hee University · KRSahmyook University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a member of neurotrophin family, brain derived neurotrophic factor (BDNF) plays critical roles in neuronal development, differentiation, synaptogenesis, and neural protection from the harmful stimuli. There have been reported that adenosine A2(A) receptor subtype is widely distributed in the brain regions, such as hippocampus, striatum, and cortex. Adenosine A2(A) receptor is colocalized with BDNF in brain regions and the functional interaction between A2(A) receptor stimulation and BDNF action has been suggested. In this study, we investigated the possibility that the activation of A2(A) receptor modulates BDNF production in rat primary cortical neuron. CGS21680, an adenosine A2(A) receptor agonist, induced BDNF expression and release. An antagonist against A2(A) receptor, ZM241385, prevented CGS21680-induced increase in BDNF production. A2(A) receptor stimulation induced the activation of Akt-GSK-3β signaling pathway and the blockade of the signaling pathway with specific inhibitors abolished the increase in BDNF production, possibly via modulation of ERK1/2-CREB pathway. The physiological roles of A2(A) receptor-induced BDNF production was demonstrated by the protection of neurons from the excitotoxicity and increased neurite extension as well as synapse formation from immature and mature neurons. Taken together, activation of A2(A) receptor regulates BDNF production in rat cortical neuron, which provides neuro-protective action.

Indexed as

AdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAnimalsBrain-Derived Neurotrophic FactorCells, CulturedCerebral CortexGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaNeuronsPhenethylaminesRatsRats, Sprague-DawleyReceptor, Adenosine A2ASignal TransductionUp-Regulation2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsBrain-Derived Neurotrophic FactorGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, ratPhenethylaminesReceptor, Adenosine A2A

Identifiers

PMID21792677
OpenAlexW2044762524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.